Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Chen

Showing results (21-30 of 146) with videos related to

Pageof 15
Sort By:
Biochemical Pharmacology|July 15, 2020
Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A reviewAxel H Schönthal, Stephen D Swenson, Thomas C Chen, et al.
Pharmaceutics|December 28, 2021
The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological BarriersThomas C Chen, Clovis O da Fonseca, Daniel Levin, et al.
Pathophysiology of Haemostasis and Thrombosis|May 19, 2006
Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agentRadu Minea, Stephen Swenson, Fritz Costa, et al.
Neurosurgical Focus|December 1, 2006
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo modelWeijun Wang, Adel Kardosh, Yuzhuang S Su, et al.
Neurosurgical Focus|May 20, 2006
Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cellsVinay Gupta, Weijun Wang, Barbara A Sosnowski, et al.
Journal of Neurosurgery|May 9, 2015
Development of the Metronomic Biofeedback Pump for leptomeningeal carcinomatosis: technical noteThomas C Chen, Gina R Napolitano, Frank Adell, et al.
Cancer Biology & Therapy|January 17, 2004
Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell linesAdel Kardosh, Martina Blumenthal, Wei Jun Wang, et al.
ACS Chemical Biology|November 6, 2018
Bioorthogonal Profiling of a Cancer Cell Proteome Identifies a Large Set of 3-Bromopyruvate Targets beyond GlycolysisNarek Darabedian, Thomas C Chen, Henrik Molina, et al.
Neural Regeneration Research|June 7, 2023
Reduced non-CpG methylation is a potential epigenetic target after spinal cord injuryZhourui Wu, Chen Li, Ran Zhu, et al.
Oncology Letters|February 6, 2019
Distribution of cancer stem cells in two human brain gliomasLilei Peng, Jie Fu, Weijun Wang, et al.
Pageof 15

Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
Biochemical Pharmacology|July 15, 2020
Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A reviewAxel H Schönthal, Stephen D Swenson, Thomas C Chen, et al.
Pharmaceutics|December 28, 2021
The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological BarriersThomas C Chen, Clovis O da Fonseca, Daniel Levin, et al.
Pathophysiology of Haemostasis and Thrombosis|May 19, 2006
Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agentRadu Minea, Stephen Swenson, Fritz Costa, et al.
Neurosurgical Focus|December 1, 2006
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo modelWeijun Wang, Adel Kardosh, Yuzhuang S Su, et al.
Neurosurgical Focus|May 20, 2006
Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cellsVinay Gupta, Weijun Wang, Barbara A Sosnowski, et al.
Journal of Neurosurgery|May 9, 2015
Development of the Metronomic Biofeedback Pump for leptomeningeal carcinomatosis: technical noteThomas C Chen, Gina R Napolitano, Frank Adell, et al.
Cancer Biology & Therapy|January 17, 2004
Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell linesAdel Kardosh, Martina Blumenthal, Wei Jun Wang, et al.
ACS Chemical Biology|November 6, 2018
Bioorthogonal Profiling of a Cancer Cell Proteome Identifies a Large Set of 3-Bromopyruvate Targets beyond GlycolysisNarek Darabedian, Thomas C Chen, Henrik Molina, et al.
Neural Regeneration Research|June 7, 2023
Reduced non-CpG methylation is a potential epigenetic target after spinal cord injuryZhourui Wu, Chen Li, Ran Zhu, et al.
Oncology Letters|February 6, 2019
Distribution of cancer stem cells in two human brain gliomasLilei Peng, Jie Fu, Weijun Wang, et al.
Pageof 15